期刊
VOX SANGUINIS
卷 100, 期 3, 页码 340-342出版社
WILEY
DOI: 10.1111/j.1423-0410.2010.01412.x
关键词
-
类别
资金
- NHS Blood and Transplant, UK
- Health Protection Agency, UK
Background and Objective The risk of hepatitis E virus (HEV) to blood safety remains unknown in England. Reports of persistent HEV infection with serious disease sequelae indicate that transfusion transmitted HEV is not a trivial disease in immunosuppressed patients. Materials and Methods Samples from unselected blood donors and donors with a history of jaundice were tested for HEV antibody and RNA. Results Overall, 10% of the donor sera were anti-HEV IgG reactive. Four of the donor samples were anti-HEV IgM reactive but HEV RNA negative. Conclusion There is evidence of probable recent HEV infections in donors with a predicted attack rate of 2 center dot 8%.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据